US AI Holds a 25-to-1 Compute Lead Over China | Chris McGuire
MTS
October 24, 2026
Chris McGuire, Senior Fellow for China and Emerging Technologies at the Council on Foreign Relations, breaks down new Treasury outbound investment restrictions, US export control loopholes, and why US AI compute leads China 25 to 1. Turn ideas into software people love.
Theo
The fact is, Chinese AI companies are just extremely dependent on US chips. Like China makes 1-4% of US computing power per year. It's really the closing loopholes in the controls that the Chinese are massively exploiting that I think it's the difference between us having a 25-to-1 compute advantage over China if they were using just their own chips, and probably a 2-to-1 or so if they're exploiting our controls and getting all this access. Which is a huge difference in AI. That's the difference between like a 6-month lead and a 2-year lead.
We're live now with Chris McGuire, who is Senior Fellow for China and Emerging Technologies at the Council on Foreign Relations, previously had a long storied career in various arms of government. Chris, welcome to MTS. Thanks a lot. Thanks for having me, Theo. Absolutely. So tell us about your post from, I believe, yesterday about the Treasury's new outbound investment regulations. What are they and what do they mean?
Yeah. So maybe first, good to take a step back and just talk about what the outbound investment restrictions are and why they exist. So basically, these are regulations that prohibit or require notification for investments into certain technology sectors in China. And they were first created in 2023 President Biden issued an executive order that directed Treasury to implement them. It was a response to a gap in the US regulatory posture where we would ban exports of certain goods to Chinese companies, but we had no equivalent restrictions on financing. So there's firms that were on the MD list. They'd be banned from buying US goods, but the US VC firms would invest in them or there'd be joint ventures with Chinese firms doing super computing, things that obviously were helping the Chinese develop these advanced technologies and pose a problem. So the US regulations before this covered three sectors, AI, semiconductors and quantum. It prohibits some types of investment, restrict others, and they covered most private investments. So private equity, venture capital, also joint ventures, greenfield investments, did not capture publicly traded securities. This was, so yesterday, the Treasury Department issued a proposed rule, so not a final rule, but a proposed rule, that would substantially expand this program. And this is in response to there was legislation from Congress that required them to put out, expand the program to certain things, also gave it a statutory basis, which is good. But it had pretty notable effects. It added two categories, biotech and hypersonics. And then also in some of the categories that existed, namely AI, substantially expanded it to be much, much broader and kind of taking away from the narrowly target approach when looking at the most advanced models to really something that would capture probably most Chinese software and also a lot of hardware robotics, things that actually use Chinese software. So this is a pretty significant expansion of the rule. I think we can talk about the impact and what it would be, but it's also important to note that this was a proposed rule, and it does not go into effect right away. And I think the purpose is to get notice and comment, talk to people in industry, in foreign governments, etc. and see what actually makes sense and then refine from there. But it is a signal that I think the administration sees as broadly as a significant issue and wants to tackle it pretty holistically.
So it does seem like the US is increasingly sort of decoupling from Chinese tech. And this has accelerated even during the Trump administration. So for example, there have been all these FCC rules restricting imports of Chinese quadrupeds and humanoids and optical transceivers and data centers and all kinds of technology. And obviously, we have our export controls on frontier AI chips to China.
So where does this end up? Do you think that we're...
It's kind of hard for me to square this with like, on the one hand, it seems like US and Chinese supply chains are pulling apart. On the other hand, like Trump's visit with President Xi was very friendly and seemed to suggest some like detente going on. So what do you think? Yeah. So I think on the one hand, look, I think that the strategy really in the first Trump administration, particularly in the Biden administration, was to kind of do diplomacy with China and make sure that we had real connections between our leaders, but also execute a real competitive agenda behind the scenes, especially on the econ tech side. And there was a recognition that really started in the first Trump administration, that the US and Chinese tech economies were way too coupled, and China was massively exploiting this to their advantage and allowing them to catch up in a lot of areas. And I think the Trump administration kind of started to push some of these away, especially in these high tech sectors. Biden administration really expanded it. So the idea that the leaders are meeting, I think isn't inherently in Congress with this competitive approach that we've seen. What is in Congress in the Trump administration is the differential in approach between agencies. As you noted, the FCC has really pursued a very aggressive agenda on import controls, which the Biden administration started initially on cars. That was the first kind of class of vehicle or class of goods that were controlled for import into the United States. They've expanded this into drones and routers and robots for reasons that I think make a lot of sense. You also have the US trade representative has obviously pursued a very broad tariff agenda. You now see Treasury significantly expanding the outbound investment rules. But with respect to the Commerce Department and export controls, we have seen much less actual work. And that is increasingly out of step with the Trump administration's approach on all these other vectors, where on export controls, which is arguably the most important one, where it's a question of just are the Chinese going to be able to get the US technology that they are using to advance themselves? That's the area where the administration has been loosening restrictions, and also kind of not pulling ones back and allowing loopholes to persist the Chinese are exploiting. So I think this probably will not, something we'll have to give. I think that this kind of bifurcated approach, where different agencies are going different ways, is just it's not going to last. The signal is clearly pursuing the stronger approach, but it's just in the area that's the most significant for US competitive interests, is still the area where we have the weakest approach. What about Chinese biotech? There's this story, I believe, in the Wall Street Journal, I think, yesterday about how Americans who are facing terrible conditions like cancer, are heading to China for treatment, because drugs that would help them are not approved in the US, but they are approved in China. So do you think that there will be something of a decoupling in American and Chinese biotech as well, that would make this kind of thing harder?
Read the other 17 minutes of this episode here.
$15 gets you this episode and 99 more. Credits never expire. After checkout, one link brings you back here to read it.
Not what you expected? Full refund within 14 days.
Thousands of transcripts fetched by people building searchable podcast archives
Fetch transcripts with code
The same credits work from a script or an AI agent. The demo key returns a sample episode in full, no card needed:
curl -H "x-api-key: pt_demo" \
https://spoken.md/transcripts/1000651996090Markdown with the speakers named, for your notes, your knowledge base, or anything that makes HTTP calls.
From $0.10 per transcript. No subscription. Credits never expire. Prices exclude VAT, added at checkout for EU customers. Not what you expected? Email us within 14 days with 20 or fewer credits used and we refund the pack in full.
Using your own key:
curl -H "x-api-key: YOUR_KEY" \
https://spoken.md/transcripts/1000797891180